Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-20

Clinical Trial Update: Study of Hemospray for Lower Gastrointestinal Hemorrhage

View source ↗

Summary

Clinical trial evaluating Hemospray for lower gastrointestinal bleeding due to colonic diverticula and angiodysplasia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemospray (TC-325)

Snippet

Sponsor: Cook Group Incorporated | Conditions: Colonic Diverticula, Angiodysplasia | Status: COMPLETED